< Back to search
Filter
1

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

for
Renal Cell Carcinoma, Urothelial Carcinoma,
Location: Boston MA, Philadelphia PA, Cleveland OH, Ann Arbor MI,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06966024

Phase1, Recruiting

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

for
Metastatic Prostate Cancer,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 19+

Code: NCT06738303

Phase2, Recruiting

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Los Angeles CA
Sponsor: Charles Drew University of Medicine and Science

Sex: Male

Age: 18+

Code: NCT06615752

Phase1, Phase2, Recruiting

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy,
Location: El Paso TX, Murray UT, Los Angeles CA
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07226986

Phase1, Phase2, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: North Hills NY, Bala-Cynwyd PA, Virginia Beach VA,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

Interested in new castration-resistant prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Myrtle Beach SC, Nashville TN, Omaha NE, Irving TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06100705

Phase2, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

for
Advanced Metastatic Castration Resistant Prostate Cancer
Location: Fairfax VA, Houston TX, San Antonio TX, Spokane WA,
Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: Male

Age: 18+

Code: NCT06609005

Phase1, Phase2, Recruiting

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

for
Metastatic Castration-Resistant Prostate Cancer,
Location: Houston TX
Sponsor: Ebrahim S Delpassand

Sex: Male

Age: 18+

Code: NCT06972628

Phase2, Recruiting

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

for
Castrate Resistant Prostate Cancer,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Male

Age: 18+

Code: NCT05766371

Phase2, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Commack NY, East Brunswick NJ, Columbus OH,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase2, Recruiting

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

for
Prostate Cancer, Prostate Adenocarcinoma,
Location: New York NY, Durham NC, Madison WI
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT06141993

Recruiting

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

for
Prostate Cancer,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Male

Age: 18+

Code: NCT06099093

Recruiting

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Durham NC, Ann Arbor MI, Madison WI, Los Angeles CA,
Sponsor: Syntrix Biosystems, Inc.

Sex: Male

Age: 18+

Code: NCT06228053

Phase2, Recruiting

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Boston MA, Sarasota FL, Grand Rapids MI, Nashville TN,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06784193

Phase1, Recruiting

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

for
Metastatic Castration-resistant Prostate Cancer
Location: New York NY, Toronto, Burnaby
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited

Sex: Male

Age: 18+

Code: NCT06520345

Phase3, Recruiting

Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer

for
Cancer of the Prostate, Castration-resistant Prostate Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: Male

Age: 18+

Code: NCT03960788

Early_phase1, Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, Baltimore MD, Myrtle Beach SC, Tampa FL,
Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male

Age: 18+

Code: NCT06801236

Phase1, Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Detroit MI
Sponsor: Celcuity Inc

Sex: Male

Age: 18+

Code: NCT06190899

Phase1, Phase2, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase1, Phase2, Recruiting